The world's first clinical trial of human insulin produced in plants is starting in the UK. The aim is to provide a new source of insulin to meet the rapidly growing demand from diabetics.SemBioSys, a Canadian biotechnology company, has developed a genetically modified variety of safflower that makes high concentrations of human insulin in its seeds. (Safflower is a thistle-like plant with large yellow flowers, which is a minor source of seed oils.)For more details please visit the following link:http://www.ft.com/cms/s/0/a69c744e-d937-11dd-ab5f-000077b07658.html
Nice & useful research,
If human trial is successfully completed, will be useful greatly. And if it is oral preparation it is also useful to reduce needle usage and their by reducing some diseases or infection casued by reuse of infected needles.
Online Survey Software powered by Cvent
Board Rules | advertise | Privacy
Copyright © 2004-2012 Scientist Solutions, All Rights Reserved.Resources from NCBI used on this site.